Medpace Holdings, Inc. (MEDP): EPS (Diluted)

Annual figures by period end, from SEC filings.

$15.28
Year ended 2025-12-31
+28.0%
3-year compound annual growth
+31.8%
5-year compound annual growth
2015-12-31: -$0.282016-12-31: $0.372017-12-31: $0.982018-12-31: $1.972019-12-31: $2.672020-12-31: $3.842021-12-31: $4.812022-12-31: $7.282023-12-31: $8.882024-12-31: $12.632025-12-31: $15.28$15.28
2015-12-31 EPS (Diluted) (USD per share) 2025-12-31
Period endedEPS (Diluted)Change YoYSource filing
2025-12-31$15.28+21.0%2026-02-10, From 2025-01-01
2024-12-31$12.63+42.2%2026-02-10, From 2024-01-01
2023-12-31$8.88+22.0%2026-02-10, From 2023-01-01
2022-12-31$7.28+51.4%2025-02-11, From 2022-01-01
2021-12-31$4.81+25.3%2024-02-13, From 2021-01-01
2020-12-31$3.84+43.8%2023-02-14, From 2020-01-01
2019-12-31$2.67+35.5%2022-02-15, From 2019-01-01
2018-12-31$1.97+101.0%2021-02-16, From 2018-01-01
2017-12-31$0.98+164.9%2020-02-25, From 2017-01-01
2016-12-31$0.37n/m2019-02-26, From 2016-01-01
2015-12-31-$0.28n/a2018-02-27, From 2015-01-01

EPS (Diluted) at similar companies

Companies with the same SEC industry code (Services-Commercial Physical & Biological Research), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEPS (Diluted)Change YoY
Medpace Holdings, Inc. (MEDP)2025-12-31$15.28+21.0%
Charles River Laboratories International, Inc. (CRL)2025-12-27-$2.91n/m
Incyte Corp (INCY)2025-12-31$6.41n/m
Icon PLC (ICLR)2025-12-31$2.90-67.4%
Iqvia Holdings Inc. (IQV)2025-12-31$7.84+4.7%
NRC Health (NRC)2025-12-31$50.00n/m
MaxCyte, Inc. (MXCT)2025-12-31-$0.42n/m
OmniAb, Inc. (OABI)2025-12-31-$0.57n/m
bioAffinity Technologies, Inc. (BIAF)2025-12-31-$8.66n/m

Compare MEDP, CRL, INCY, ICLR side by side · Screen every company in Services-Commercial Physical & Biological Research ↗